Cancer Res (2022) 82 (12_Supplement): 3595. Combination treatment with RMC-6291 and SHP2 or SOS1 inhibitors was well tolerated in preclinical models and further increased anti-tumor activity, likely ...
Introduction: The tumor microenvironment (TME) is a dynamic and multifaceted system that comprises largely myeloid lineage immune cells including monocytes, neutrophils, macrophages, and dendritic ...
Cancer Res (2022) 82 (12_Supplement): 5462.
Cancer Res (2024) 84 (6_Supplement): 7536.
The 2025 Nobel Prize in Physics recognizes the discovery of quantum tunneling, now a foundation of quantum computing. That same physics is beginning to reshape cancer research, from drug design and ...
Cancer Res (2024) 84 (17_Supplement): A006.
1Yonsei University, College of Medicine, Seoul, Republic of Korea.
1Laboratory of Rare Human Circulating Cells (LCCRH), University Medical Centre of Montpellier, Montpellier, France.
1Department of Medical Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
1Moffitt Cancer Center, Tampa, FL. Search for other works by this author on: ...
1Department of Oncology, University of Lausanne, Lausanne, Switzerland.
Cancer Res (2023) 83 (8_Supplement): LB031.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback